Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2026

Retirement of Director

11 February 20266 February 2026 by Karen Mobbs

Retirement of Director

Categories 2026, ASX Announcements

Supplementary Prospectus

1 February 202630 January 2026 by Karen Mobbs

Supplementary Prospectus

Categories 2026, ASX Announcements

Appendix 2A Application for quotation of securities

1 February 202630 January 2026 by Karen Mobbs

Appendix 2A Application for quotation of securities

Categories 2026, ASX Announcements

Successful Issue of the Entitlement Offer Shortfall

1 February 202630 January 2026 by Karen Mobbs

Successful Issue of the Entitlement Offer Shortfall

Categories 2026, ASX Announcements

Quarterly Report 31 December 2025

1 February 202629 January 2026 by Karen Mobbs

Quarterly Report 31 December 2025

Categories 2026, ASX Announcements, Quarterly Reports
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 11 February 2026        Legal Notices and Privacy
Cleantalk Pixel